Hughes Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.9K Buy
1,324
+102
+8% +$2.67K ﹤0.01% 218
2026
Q1
$34.3K Buy
1,222
+168
+16% +$4.47K 0.01% 200
2025
Q4
$26.3K Buy
1,054
+352
+50% +$8.88K ﹤0.01% 206
2025
Q3
$17.1K Buy
702
+181
+35% +$4.47K ﹤0.01% 237
2025
Q2
$12.5K Sell
521
-59
-10% -$1.38K ﹤0.01% 280
2025
Q1
$14.2K Buy
+580
New +$15.2K ﹤0.01% 270

Other funds holding PFE

Hughes Financial Services's PFE Position: Q2 2026 in Review

Hughes Financial Services increased its Pfizer (PFE) stake by 8.3% in Q2 2026, buying an estimated $2.67K and bringing the position to 1,324 shares worth $31.9K. The position accounts for ﹤0.01% of the portfolio, ranked #218.

Hughes Financial Services first reported a position in PFE in Q1 2025 and has held it in 6 quarters since. The position peaked at $34.3K in Q1 2026. 799 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Hughes Financial Services held 1,324 shares of Pfizer worth $31.9K as of Q2 2026.
  • Hughes Financial Services bought 102 Pfizer shares in Q2 2026, an estimated $2.67K.
  • Pfizer made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #218 holding.
  • Hughes Financial Services first reported a position in Pfizer in Q1 2025 and has held it in 6 quarters since.
  • Hughes Financial Services's Pfizer position peaked at $34.3K in Q1 2026.
  • 799 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.